Glycorex Transplantation AB Stock
Equities
GTAB B
SE0000524530
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.842 SEK | -0.94% | -3.44% | -36.45% |
Sales 2021 | 29.01M 2.67M | Sales 2022 | 37.39M 3.45M | Capitalization | 303M 27.92M |
---|---|---|---|---|---|
Net income 2021 | -12M -1.11M | Net income 2022 | -8M -738K | EV / Sales 2021 | 22.5 x |
Net cash position 2021 | 33.08M 3.05M | Net cash position 2022 | 23.52M 2.17M | EV / Sales 2022 | 7.47 x |
P/E ratio 2021 |
-56.1
x | P/E ratio 2022 |
-35.3
x | Employees | 23 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 95.58% |
1 day | +2.41% | ||
1 week | +4.68% | ||
1 month | -4.28% | ||
3 months | -39.29% | ||
6 months | -51.01% | ||
Current year | -35.85% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Laven
CEO | Chief Executive Officer | 51 | 21-12-31 |
Founder | 71 | 95-12-31 | |
Sales & Marketing | - | 22-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 71 | 95-12-31 | |
Nils Siegbahn
CHM | Chairman | 71 | 99-12-31 |
Clas Runnberg
BRD | Director/Board Member | 72 | 22-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-15 | 0.842 | -0.94% | 32,819 |
24-04-12 | 0.85 | +2.41% | 85,999 |
24-04-11 | 0.83 | +2.47% | 14,800 |
24-04-10 | 0.81 | -4.71% | 107,819 |
24-04-09 | 0.85 | -2.52% | 22,594 |
End-of-day quote NORDIC GROWTH MARKET, April 11, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-35.85% | 5.76M | |
-36.79% | 2.78B | |
-10.63% | 2.67B | |
-4.54% | 2B | |
+0.74% | 1.95B | |
-17.93% | 1.56B | |
-8.89% | 1.38B | |
-3.50% | 1.26B | |
+17.30% | 1.16B | |
+4.39% | 1.11B |
- Stock Market
- Equities
- GTAB B Stock